Clinical trial
Real-World Data for Effectiveness and Safety of Palopegteriparatide in Patients With Chronic Hypoparathyroidism in Greece
NCT07299838 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Data for Effectiveness and Safety of Palopegteriparatide in Patients With Chronic Hypoparathyroidism in Greece
- Lead sponsor
- National and Kapodistrian University of Athens
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2024
- Completion date
- October 23, 2025
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.